DIETHANOLAMINE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 105.0 | -1.4 | 3 | 3 | 52.0 | 4 | 1.0 |
- CAS
- 111422
- UNII
- AZE05TDV2V
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 57 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT01934582 | 2013-08-01 | A Pharmacokinetic Substudy of the TDE-PH-304 Protocol | Phase 3 | Active, Not Recruiting |
| NCT01560624 | 2012-07-01 | Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension | Phase 3 | Recruiting |
| NCT01560637 | 2012-05-01 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | Phase 3 | Recruiting |
| NCT01172496 | 2010-08-01 | A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers | Phase 1 | Completed |
| NCT01153386 | 2010-07-01 | Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine | Phase 1 | Completed |
| NCT01165476 | 2010-07-01 | Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities | Phase 1 | Completed |
| NCT01131845 | 2010-05-01 | The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil | Phase 1 | Completed |
| NCT00963001 | 2009-09-01 | Effect of Food on the Pharmacokinetics of Oral Treprostinil | Phase 1 | Completed |
| NCT00963027 | 2009-09-01 | Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil | Phase 1 | Completed |
| NCT00848107 | 2009-09-01 | Open-Label Study of Oral Treprostinil in Digital Ulcers | Phase 2 | Terminated |
| NCT00775463 | 2009-05-01 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | Phase 2 | Completed |
| NCT00848939 | 2008-12-01 | Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis | Phase 1 | Completed |
| NCT00445159 | 2006-11-01 | UT-15C SR in the Treatment of Critical Limb Ischemia | Phase 2 | Recruiting |
| NCT01027949 | 2006-05-01 | An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension | Phase 3 | Active, Not Recruiting |